Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://zakariaqhzq368686.digitollblog.com/38902380/trelaglutide-exploring-a-new-therapy-for-chronic-diseases